PE20191133A1 - Cristal de derivado de pirido[3,4-d]pirimidina o su solvato - Google Patents
Cristal de derivado de pirido[3,4-d]pirimidina o su solvatoInfo
- Publication number
- PE20191133A1 PE20191133A1 PE2019001068A PE2019001068A PE20191133A1 PE 20191133 A1 PE20191133 A1 PE 20191133A1 PE 2019001068 A PE2019001068 A PE 2019001068A PE 2019001068 A PE2019001068 A PE 2019001068A PE 20191133 A1 PE20191133 A1 PE 20191133A1
- Authority
- PE
- Peru
- Prior art keywords
- crystal
- pyrid
- refers
- compound
- solvate
- Prior art date
Links
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 title 1
- 239000013078 crystal Substances 0.000 title 1
- 239000012453 solvate Substances 0.000 title 1
- -1 ISOPROPYLAMINO Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 208000003174 Brain Neoplasms Diseases 0.000 abstract 1
- 229940124297 CDK 4/6 inhibitor Drugs 0.000 abstract 1
- 238000002441 X-ray diffraction Methods 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 201000008247 brain infarction Diseases 0.000 abstract 1
- 206010008118 cerebral infarction Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 208000005069 pulmonary fibrosis Diseases 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 238000001228 spectrum Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Walking Sticks, Umbrellas, And Fans (AREA)
Abstract
SE REFIERE A UN CRISTAL DE UN COMPUESTO DE FORMULA (I) DONDE R1 ES H O UN GRUPO ALQUILO C1-C3; R2 ES H O UN GRUPO OXO; L ES UN ENLACE SIMPLE O UN GRUPO ALQUILENO C1-C3; X ES CH O N; EN DONDE EL CRISTAL DEL COMPUESTO 1-(6-((6-((1R)-1-HIDROXIETIL)-8-(ISOPROPILAMINO)PIRIDO[3,4-D]PIRIMIDIN-2-IL)AMINO)-3-PIRIDIL)PIPERAZIN-2-ONA EXHIBE PICOS EN ANGULOS DE DIFRACCION 2THETA IGUALES A 6.3°, 6.6°, 11.6°, 16.9° Y 20.0° EN UN ESPECTRO DE DIFRACCION DE RAYOS X DE POLVOS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA. DICHO CRISTAL TIENE UNA ACTIVIDAD INHIBIDORA DE CDK4/6 SIENDO UTIL EN EL TRATAMIENTO DE ARTRITIS REUMATOIDE, ARTERIOSCLEROSIS, FIBROSIS PULMONAR, INFARTO CEREBRAL O CANCER
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016229973 | 2016-11-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20191133A1 true PE20191133A1 (es) | 2019-09-02 |
Family
ID=62196036
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2019001068A PE20191133A1 (es) | 2016-11-28 | 2017-11-27 | Cristal de derivado de pirido[3,4-d]pirimidina o su solvato |
| PE2023003166A PE20250397A1 (es) | 2016-11-28 | 2017-11-27 | Cristal de derivado de pirido[3,4-d]pirimidina o su solvato |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2023003166A PE20250397A1 (es) | 2016-11-28 | 2017-11-27 | Cristal de derivado de pirido[3,4-d]pirimidina o su solvato |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US11261182B2 (es) |
| EP (1) | EP3546456B1 (es) |
| JP (2) | JP6745905B2 (es) |
| KR (1) | KR102352637B1 (es) |
| CN (1) | CN109996800B (es) |
| AU (1) | AU2017364805B2 (es) |
| CA (1) | CA3041854C (es) |
| CL (3) | CL2019001420A1 (es) |
| CO (1) | CO2019005513A2 (es) |
| CY (1) | CY1125045T1 (es) |
| DK (1) | DK3546456T3 (es) |
| EC (1) | ECSP19037197A (es) |
| ES (1) | ES2905437T3 (es) |
| HR (1) | HRP20220065T1 (es) |
| HU (1) | HUE057706T2 (es) |
| IL (1) | IL266313B2 (es) |
| LT (1) | LT3546456T (es) |
| MA (1) | MA45887B1 (es) |
| MX (1) | MX382362B (es) |
| MY (1) | MY199852A (es) |
| NZ (1) | NZ752990A (es) |
| PE (2) | PE20191133A1 (es) |
| PH (1) | PH12019500905A1 (es) |
| PL (1) | PL3546456T3 (es) |
| PT (1) | PT3546456T (es) |
| RS (1) | RS63004B1 (es) |
| SI (1) | SI3546456T1 (es) |
| TW (1) | TWI755452B (es) |
| UA (1) | UA124273C2 (es) |
| WO (1) | WO2018097295A1 (es) |
| ZA (1) | ZA201902828B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240130693A (ko) * | 2021-12-16 | 2024-08-29 | 트랜스테라 사이언시즈 (난징), 인크. | Cdk9 억제제 및 이의 용도 |
| WO2025070601A1 (ja) * | 2023-09-27 | 2025-04-03 | 帝人ファーマ株式会社 | 関節リウマチ治療薬 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4291696B2 (ja) | 2002-01-22 | 2009-07-08 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | ２−（ピリジン−２−イルアミノ）−ピリド［２，３−ｄ］ピリミジン−７−オン |
| WO2004065378A1 (en) * | 2003-01-17 | 2004-08-05 | Warner-Lambert Company Llc | 2-aminopyridine substituted heterocycles as inhibitors of cellular proliferation |
| JP4053073B2 (ja) | 2003-07-11 | 2008-02-27 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | 選択的ｃｄｋ４阻害剤のイセチオン酸塩 |
| ES2522346T3 (es) | 2008-08-22 | 2014-11-14 | Novartis Ag | Compuestos de pirrolopirimidina como inhibidores de CDK |
| GB201216017D0 (en) | 2012-09-07 | 2012-10-24 | Cancer Rec Tech Ltd | Inhibitor compounds |
| AU2014308616B2 (en) * | 2013-08-23 | 2018-12-06 | Neupharma, Inc. | Certain chemical entities, compositions, and methods |
| GB201403536D0 (en) | 2014-02-28 | 2014-04-16 | Cancer Rec Tech Ltd | Inhibitor compounds |
| ES2703168T3 (es) * | 2014-05-29 | 2019-03-07 | Taiho Pharmaceutical Co Ltd | Nuevo compuesto de tetrahidropiridopirimidina o sal del mismo |
| KR20170048591A (ko) | 2014-09-17 | 2017-05-08 | 셀젠 콴티셀 리서치, 인크. | 히스톤 데메틸라제 억제제 |
| KR102601320B1 (ko) * | 2015-05-29 | 2023-11-10 | 데이진 화-마 가부시키가이샤 | 피리도[3,4-d]피리미딘 유도체 및 그 약학적으로 허용되는 염 |
-
2017
- 2017-11-27 RS RS20220187A patent/RS63004B1/sr unknown
- 2017-11-27 MY MYPI2019002381A patent/MY199852A/en unknown
- 2017-11-27 CN CN201780073120.6A patent/CN109996800B/zh active Active
- 2017-11-27 MA MA45887A patent/MA45887B1/fr unknown
- 2017-11-27 HR HRP20220065TT patent/HRP20220065T1/hr unknown
- 2017-11-27 EP EP17873876.1A patent/EP3546456B1/en active Active
- 2017-11-27 NZ NZ752990A patent/NZ752990A/en unknown
- 2017-11-27 LT LTEPPCT/JP2017/042437T patent/LT3546456T/lt unknown
- 2017-11-27 UA UAA201905840A patent/UA124273C2/uk unknown
- 2017-11-27 CA CA3041854A patent/CA3041854C/en active Active
- 2017-11-27 WO PCT/JP2017/042437 patent/WO2018097295A1/ja not_active Ceased
- 2017-11-27 AU AU2017364805A patent/AU2017364805B2/en active Active
- 2017-11-27 US US16/463,501 patent/US11261182B2/en active Active
- 2017-11-27 SI SI201731055T patent/SI3546456T1/sl unknown
- 2017-11-27 HU HUE17873876A patent/HUE057706T2/hu unknown
- 2017-11-27 TW TW106141156A patent/TWI755452B/zh active
- 2017-11-27 PE PE2019001068A patent/PE20191133A1/es unknown
- 2017-11-27 PT PT178738761T patent/PT3546456T/pt unknown
- 2017-11-27 PE PE2023003166A patent/PE20250397A1/es unknown
- 2017-11-27 DK DK17873876.1T patent/DK3546456T3/da active
- 2017-11-27 MX MX2019005717A patent/MX382362B/es unknown
- 2017-11-27 IL IL266313A patent/IL266313B2/en unknown
- 2017-11-27 JP JP2018553004A patent/JP6745905B2/ja active Active
- 2017-11-27 ES ES17873876T patent/ES2905437T3/es active Active
- 2017-11-27 PL PL17873876T patent/PL3546456T3/pl unknown
- 2017-11-27 KR KR1020197015052A patent/KR102352637B1/ko active Active
-
2019
- 2019-04-24 PH PH12019500905A patent/PH12019500905A1/en unknown
- 2019-05-06 ZA ZA2019/02828A patent/ZA201902828B/en unknown
- 2019-05-24 CL CL2019001420A patent/CL2019001420A1/es unknown
- 2019-05-27 EC ECSENADI201937197A patent/ECSP19037197A/es unknown
- 2019-05-27 CO CONC2019/0005513A patent/CO2019005513A2/es unknown
-
2020
- 2020-04-06 JP JP2020068663A patent/JP7149980B2/ja active Active
-
2021
- 2021-06-02 CL CL2021001448A patent/CL2021001448A1/es unknown
- 2021-06-02 CL CL2021001447A patent/CL2021001447A1/es unknown
-
2022
- 2022-03-04 CY CY20221100183T patent/CY1125045T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2020003425A1 (es) | Nuevos derivados heterocíclicos útiles como inhibidores de shp2 (divisional solicitud n° 201902698) | |
| CY1124800T1 (el) | Παραγωγο πυριδο[3,4-d]πυριμιδινης και φαρμακευτικως αποδεκτο αλας αυτου | |
| MX2016015544A (es) | Nuevos derivados de pirazolo pirimidina y su uso como inhibidores de malt1. | |
| MX2017007748A (es) | Compuestos de heteroarilo anulares fusionados y su uso como inhibidores del receptor de la tirocina cinasa (trk). | |
| MX2020007265A (es) | Derivados de rapamicina. | |
| WO2015058126A8 (en) | Heteroaromatic compounds useful for the treatment of prolferative diseases | |
| EA201691428A1 (ru) | Бициклические гетероциклические производные в качестве ингибиторов irak4 | |
| MX388321B (es) | Compuestos de aminopurina sustituida, composiciones del mismo, y metodos de tratamiento con los mismos. | |
| EA201991127A1 (ru) | ЦИКЛОБУТАН- И АЗЕТИДИНСОДЕРЖАЩИЕ МОНО- И СПИРОЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ ИНТЕГРИНА αV | |
| MX374729B (es) | Compuestos de heteroarilo o arilo biciclicos fusionados y su uso como inhibidores irak4. | |
| MX2016012967A (es) | Inhibidores de la quinasa dependiente de ciclina 7 (cdk7). | |
| WO2015058163A3 (en) | Heteromaromatic compounds useful for the treatment of prolferative diseases | |
| PH12015502038A1 (en) | 2,3-disubstituted 1 -acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors | |
| NZ715838A (en) | Pyridines, pyrimidines, and pyrazines, as btk inhibitors and uses thereof | |
| PE20151764A1 (es) | Derivados de pirrolo[2,3-d]pirimidina | |
| UY36244A (es) | Derivados de la pirimidinona como inhibidores del factor xia y/o de la calicreína plasmática y composiciones farmacéuticas que los contienen | |
| MX375372B (es) | COMPOSICIONES DE COMPUESTOS DE MOLÉCULA PEQUEÑA Y USO DE LOS MISMOS COMO INHIBIDORES TrKA. | |
| MD20160089A2 (ro) | Analogi ai cortistatinului, sinteza şi utilizările acestora | |
| GEP20227344B (en) | Pyrimidine compound as jak kinase inhibitor | |
| MX2016013329A (es) | 2-amino-6-metil-4,4a,5,6-tetrahidropirano[3,4-d][1,3]tiazin-8a(8h )-il-1,3-tiazol-4-ilamidas. | |
| UA113470C2 (xx) | Піримідинові та піридинові сполуки та їх застосування | |
| BR112018005851A2 (pt) | derivados de pirrolo[2,3-d]pirimidina como inibidores de dyrk1 / clk1 duais | |
| CY1123850T1 (el) | Παραγωγα ((πυριδιν-2-υλ)αμινο)πυριδο[3,4-d]πυριμιδινης και ((πυριδαζιν-3-υλ)αμινο)πυριδο[3,4-d]πυριμιδινης ως αναστολεις cdk4/6 για την αγωγη π.χ. της ρευματοειδους αρθριτιδας, της αρτηριοσκληρυνσης, της πνευμονικης ινωσης, του εγκεφαλικου εμφρακτου ή του καρκινου | |
| EA201790016A1 (ru) | АНАЛОГ ПИРИДИНО[1,2-a]ПИРИМИДОНА, ПРИМЕНЯЕМЫЙ В КАЧЕСТВЕ ИНГИБИТОРА PI3K | |
| DOP2015000214A (es) | Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a |